Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health’s industry-leading software systems provide the platform for the company’s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty clinics across North America.

T​​hrough Alternate Health’s subsidiary, Blaine Labs, the Company is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health’s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders. For more information about Alternate Health Corp., visit www.alternatehealth.com.

 

 

AMP is licensed to import European Union - Good Manufacturing Practice (EU-GMP) medical cannabis from Europe and elsewhere into Germany. AMP sources, stores, transports, delivers, and sells medical cannabis products to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients with a physician’s prescription.  

Asia Green Biotechnology Corp. is an early stage agricultural and biotechnology company focusing, first, on the introduction and application of new and important hemp strains in various regions of Asia, and, second, the conduct of research and testing to develop and introduce new and important industrial, medicinal and alternative by-products derived from those hemp and related plant strains.

Each Right entitles the holder to receive, for no additional consideration, one-tenth of one Subordinate Voting Share, subject to certain adjustments. Any Right that has not been converted by 5:00 p.m. on May 24, 2021 shall be null and void.

Ayr Strategies Inc. - Subordinate Voting Shares

Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator, focused on delivering the highest quality cannabis products and customer experience throughout its footprint. Based on the belief that everything starts with the quality of the plant, the Company is focused on superior cultivation to grow superior branded cannabis products. Ayr strives to enrich consumers’ experience every day through the wellness and wonder of cannabis.

Ayr’s leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they touch. For more information, please visit www.ayrwellness.com.

Investor Note: In addition to the 34,149,557 Subordinate Voting Shares that are listed and trading, there are (a) 3,696,486 reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares that are issued and outstanding but not listed and (b) 1,912,592 reserved for issuance pursuant to the conversion rights attached to the Exchangeable Shares issued and outstanding but not listed. The total number of issued Subordinate Voting Shares assuming all the foregoing are exercised or converted into the listed class or issued, as applicable, would be 39,758,635. The foregoing does not include the Subordinate Voting Shares reserved for issuance pursuant to the (w) exercise rights attached the Warrants which are issued and outstanding and listed, (x) conversion rights attached to the Rights which are issued and outstanding and listed, (y) conversion rights attached to the Restricted Exchangeable Shares granted as equity incentive compensation that are granted but not listed, and (z) conversion rights attached to the Restricted Exchangeable shares that are available for issuance under Ayr’s long-term equity incentive plan but not granted.  The number representing the "total equity shares, as if converted" does not take into account the Subordinate Voting Shares resulting from the exercise of the Warrants or the conversion of the Rights.

Each Warrant is exercisable to purchase one Subordinate Voting Share at a price of C$11.50 per share, subject to certain adjustments. The Warrants expire on May 24, 2024, and Ayr may accelerate such expiry (except with respect to Warrants held by Mercer Park CB, L.P., the sponsor of CSAC) by providing 30 days’ notice in the event that the closing price of the Subordinate Voting Shares equals or exceeds C$18.00 (as may adjusted in accordance with the terms thereof) for any 20 trading days within a 30-day trading period, in which case the expiry date shall be the date which is 30 days following the date on which such notice is provided. 

 

Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator, focused on delivering the highest quality cannabis products and customer experience throughout its footprint. Based on the belief that everything starts with the quality of the plant, the Company is focused on superior cultivation to grow superior branded cannabis products. Ayr strives to enrich consumers’ experience every day through the wellness and wonder of cannabis.

Ayurcann Holdings Corp. is a leading provider of customized post-harvest outsourcing solutions to licensed cannabis producers. Ayurcann Holdings Corp. concentrates on the post-harvest requirements of licensed cannabis producers and other brands looking to enter the cannabis market. Ayurcann Holdings Corp. offers end-to-end full outsourcing solutions including extraction, refinement, formulation, packaging, fulfillment and distribution.

Based in Vancouver, British Columbia, BC Craft Supply Co. has aggregated the best legacy-era talent from Canada's craft cannabis industry, which boasts an international reputation. The team at BC Craft supports the most talented cannabis cultivators in Canada to transition into their supply chain, bringing with them their unique cultivars and years of experience with the plant. In exchange for support with licensing, compliance and distribution, cultivators will sign on as a BC Craft supplier. This makes BC Craft uniquely positioned to be the premium cannabis brand in Canada. 

BC Craft’s subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a license to sell medical cannabis products in Canada.

The Issuer is an United States multi-state cannabis CPG company that reaches over 113 million Americans across California, Colorado, Florida, Illinois, Maryland, Nevada, Michigan and Oklahoma, with a portfolio of cannabis brands.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Advertisement

Publicité